# Oral Lactobacillus Reuteri for Skin Barrier Dysfunction in Obesity

> **NCT07512050** · NA · NOT_YET_RECRUITING · sponsor: **Shenzhen People's Hospital** · enrollment: 140 (estimated)

## Conditions studied

- Skin Barrier to Water Loss
- Microbial Colonization

## Interventions

- **BIOLOGICAL:** Oral Lactobacillus reuteri group
- **BIOLOGICAL:** Oral administration of inactive Lactobacillus reuteri group

## Key facts

- **NCT ID:** NCT07512050
- **Lead sponsor:** Shenzhen People's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-10
- **Primary completion:** 2026-06-28
- **Final completion:** 2026-07-30
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2026-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07512050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07512050, "Oral Lactobacillus Reuteri for Skin Barrier Dysfunction in Obesity". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07512050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*